BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21057542)

  • 1. Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.
    Yang L; Wang H; Kornblau SM; Graber DA; Zhang N; Matthews JA; Wang M; Weber DM; Thomas SK; Shah JJ; Zhang L; Lu G; Zhao M; Muddasani R; Yoo SY; Baggerly KA; Orlowski RZ
    Oncogene; 2011 Mar; 30(11):1329-40. PubMed ID: 21057542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma.
    Misiewicz-Krzeminska I; Sarasquete ME; Vicente-Dueñas C; Krzeminski P; Wiktorska K; Corchete LA; Quwaider D; Rojas EA; Corral R; Martín AA; Escalante F; Bárez A; García JL; Sánchez-García I; García-Sanz R; San Miguel JF; Gutiérrez NC
    Clin Cancer Res; 2016 Jan; 22(1):207-17. PubMed ID: 26341922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status.
    Quinn J; Glassford J; Percy L; Munson P; Marafioti T; Rodriguez-Justo M; Yong K
    Blood; 2011 Jan; 117(3):890-901. PubMed ID: 20709908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.
    Zhang X; Jing Y; Qin Y; Hunsucker S; Meng H; Sui J; Jiang Y; Gao L; An G; Yang N; Orlowski RZ; Yang L
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1166-73. PubMed ID: 22531714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression.
    Yang L; Hamilton SR; Sood A; Kuwai T; Ellis L; Sanguino A; Lopez-Berestein G; Boyd DD
    Cancer Res; 2008 Jun; 68(11):4321-30. PubMed ID: 18519692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma.
    Mansoor A; Akhter A; Pournazari P; Mahe E; Shariff S; Farooq F; Elyamany G; Shahbani-Rad MT; Rashid-Kolvear F
    Appl Immunohistochem Mol Morphol; 2015; 23(5):327-33. PubMed ID: 25265432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma.
    Bergsagel PL; Kuehl WM; Zhan F; Sawyer J; Barlogie B; Shaughnessy J
    Blood; 2005 Jul; 106(1):296-303. PubMed ID: 15755896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.
    Brito JL; Walker B; Jenner M; Dickens NJ; Brown NJ; Ross FM; Avramidou A; Irving JA; Gonzalez D; Davies FE; Morgan GJ
    Haematologica; 2009 Jan; 94(1):78-86. PubMed ID: 19059936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.
    Våtsveen TK; Tian E; Kresse SH; Meza-Zepeda LA; Gabrea A; Glebov O; Dai HY; Sundan A; Kuehl WM; Børset M
    Leuk Res; 2009 Dec; 33(12):1670-7. PubMed ID: 19395026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.
    Kawahara T; Inoue S; Ide H; Kashiwagi E; Ohtake S; Mizushima T; Li P; Li Y; Zheng Y; Uemura H; Netto GJ; Ishiguro H; Miyamoto H
    Oncotarget; 2016 Aug; 7(33):53599-53610. PubMed ID: 27447553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis and a consequent classification of multiple myeloma.
    Bergsagel PL; Kuehl WM
    J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
    Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
    Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of primary MAFB target genes in multiple myeloma.
    van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
    Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZKSCAN3 promotes breast cancer cell proliferation, migration and invasion.
    Chi Y; Xu H; Wang F; Chen X; Shan Z; Sun Y; Fan Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2583-2589. PubMed ID: 30049438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
    Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
    Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early genetic events provide the basis for a clinical classification of multiple myeloma.
    Kuehl WM; Bergsagel PL
    Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Immunol Rev; 2003 Aug; 194():96-104. PubMed ID: 12846810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.
    Hanamura I; Iida S; Akano Y; Hayami Y; Kato M; Miura K; Harada S; Banno S; Wakita A; Kiyoi H; Naoe T; Shimizu S; Sonta SI; Nitta M; Taniwaki M; Ueda R
    Jpn J Cancer Res; 2001 Jun; 92(6):638-44. PubMed ID: 11429052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma.
    Zhu L; Somlo G; Zhou B; Shao J; Bedell V; Slovak ML; Liu X; Luo J; Yen Y
    Mol Cancer Ther; 2005 May; 4(5):787-98. PubMed ID: 15897243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.